Upper GI bleeding (UGIB) ranges from self-limited mucosal bleeding to life-threatening hemorrhagic shock. Early risk stratification, resuscitation, and targeted therapy reduce mortality, rebleeding, and missed variceal hemorrhage.
At the Bedside
- Initial priorities
- Assess airway, breathing, circulation immediately.
- Look for shock: tachycardia, hypotension, altered mental status, cool extremities, low urine output.
- Consider early airway protection if massive hematemesis, ongoing emesis, inability to protect airway, severe encephalopathy, or anticipated endoscopy in unstable patient.
- Focused history
- Hematemesis, coffee-ground emesis, melena, hematochezia with brisk bleed.
- Liver disease, alcohol use, known varices, prior GI bleed, peptic ulcer disease.
- NSAIDs, anticoagulants, antiplatelets, steroids.
- Symptoms of perforation or ischemia: severe pain, rigid abdomen.
- Exam
- Hemodynamic status, stigmata of cirrhosis, abdominal tenderness, rectal exam for melena/hematochezia.
- Signs of chronic anemia vs acute blood loss.
- Workup
- CBC, CMP, LFTs, PT/INR, type and screen/cross.
- BUN often elevated in UGIB.
- VBG/ABG and lactate if ill-appearing.
- ECG in older patients or those with chest pain/ischemia risk.
- Consider POCUS for volume status; it does not diagnose source but helps shock assessment.
- Resuscitation
- Two large-bore IVs or central access if needed.
- Crystalloid only as bridge; prioritize blood in significant hemorrhage.
- Transfuse PRBCs generally if Hgb <7 g/dL in most patients; consider higher threshold (often <8 g/dL) in active ischemia, significant CAD, or persistent shock.
- Massive transfusion protocol if unstable with ongoing large-volume bleeding.
- Source-directed treatment
- Nonvariceal suspected bleed: IV PPI.
- Variceal suspected bleed: octreotide + ceftriaxone + urgent GI.
- Reverse clinically significant coagulopathy when appropriate:
- Warfarin: 4-factor PCC + IV vitamin K.
- Dabigatran: idarucizumab if severe/life-threatening bleeding.
- Apixaban/rivaroxaban: andexanet alfa where available, or PCC per protocol.
- Platelet transfusion may be indicated in severe thrombocytopenia/ongoing hemorrhage; thresholds vary by scenario and procedure.
- Consults / definitive therapy
- GI for urgent endoscopy.
- ICU if unstable, ongoing transfusion need, variceal bleed, significant comorbidity.
- Interventional radiology or surgery if endoscopic control fails.
- Disposition decision points
- Admit most patients with confirmed/suspected significant UGIB.
- Very low-risk patients may be discharged only if hemodynamically stable, no ongoing bleeding, reassuring labs, low-risk score, and reliable follow-up.
A Classic Presentation
A 58-year-old man with cirrhosis and prior varices presents with large-volume hematemesis, lightheadedness, and melena. He is tachycardic to 128, BP 88/54, pale, and intermittently confused. Two large-bore IVs are placed, type and cross sent, PRBCs started, and he receives octreotide, ceftriaxone, and IV pantoprazole. Because he continues vomiting blood and cannot protect his airway, he is intubated for airway protection before urgent endoscopy, which identifies bleeding esophageal varices.
Study Directive
- Memorize the immediate medication bundle for suspected variceal bleed: octreotide, ceftriaxone, blood, GI.
- Practice a 60-second UGIB resuscitation script: airway triggers, IV access, labs, transfusion threshold, reversal options.
- Draw a one-page comparison of variceal vs nonvariceal UGIB management from memory.
- Review anticoagulant reversal dosing in your institution’s formulary today.
- Do 10 board-style questions on GI bleed risk stratification and transfusion thresholds.